Aspen Aerogels shares plummeted nearly 20% pre-market after reporting a 66% revenue drop to $41.3 million, missing analyst expectations. The company swung to a net loss and launched a strategic review with Piper Sandler. Additionally, weak first-quarter revenue guidance of $35 million to $40 million added to investor concerns regarding its positioning.